Wells Fargo
AGIO icon

Wells Fargo’s Agios Pharmaceuticals AGIO Stock Holding History

Wells Fargo’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-73,100
Closed -$10K – 6357
2018
Q3 		$10K Buy
+73,100
New +$5.88M ﹤0.01% 5983

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Wells Fargo's AGIO Position: Q1 2026 in Review

Wells Fargo reduced its Agios Pharmaceuticals (AGIO) stake by 65% in Q1 2026, selling an estimated $1.19M and leaving 22,763 shares worth $770K. The position accounts for ﹤0.01% of the portfolio, ranked #3899.

Wells Fargo first reported a position in AGIO in Q3 2013 and has held it in 51 quarters since. The position peaked at $55.1M in Q3 2018. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Wells Fargo held 22,763 shares of Agios Pharmaceuticals worth $770K as of Q1 2026.
  • Wells Fargo sold 42,009 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.19M.
  • Agios Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3899 holding.
  • Wells Fargo first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
  • Wells Fargo's Agios Pharmaceuticals position peaked at $55.1M in Q3 2018.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.